Literature DB >> 10872735

Studies of the role of the central nucleus of the amygdala in controlling cardiovascular functions.

O G Baklavadzhyan1, N L Pogosyan, A V Arshakyan, A G Darbinyan, A V Khachatryan, T G Nikogosyan.   

Abstract

Studies on cats anesthetized with a mixture of chloralose and Nembutal addressed the effects of high-frequency stimulation (100 impulses/sec) of the central nucleus of the amygdala on bioelectrical activity in two postganglionic sympathetic nerves-the inferior cardiac nerve and the vertebral branch of the stellate ganglion, which innervate the coronary vessels and the vessels of the anterior thorax respectively. The central nucleus of the amygdala was found to have differential, selective effects, in most experiments producing increases in the amplitude of integrated activity in the inferior cardiac nerve and decreases in the amplitude of biopotentials in the vertebral nerve. In a few experiments, a second type of modulation of the activities of these two postganglionic nerves was seen, with selective inhibition of activity in the inferior cardiac nerve and an accompanying increase in activity in the vertebral nerve. Stimulation of the central nucleus of the amygdala induced significant increases in systemic arterial blood pressure. The role of the central nucleus of the amygdala in the development of experimental neurogenic hypertension was studied in a series of chronic experiments on rats; these established that rats subjected to bilateral electrolytic lesioning of the central nucleus of the amygdala prevented the development of neurogenic hypertension induced by daily imposition of stress for four weeks for induction of operant aversive conditioned reflexes, which was not the case in control rats. The role of the central nucleus of the amygdala in the regulation of vascular tone is discussed.

Entities:  

Mesh:

Year:  2000        PMID: 10872735     DOI: 10.1007/bf02463163

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  13 in total

1.  Relation of cardiovascular changes in fighting to emotion and exercise.

Authors:  D B Adams; G Baccelli; G Mancia; A Zanchetti
Journal:  J Physiol       Date:  1971-01       Impact factor: 5.182

2.  [A model for the development of hypertonic blood pressure dysregulation following miscontrolled learning].

Authors:  K Hecht; K Treptow; M Poppei; T Hecht
Journal:  Acta Biol Med Ger       Date:  1971

3.  Influence of vasoconstrictor nerve activity on the cholinergic vasodilator response in skeletal muscle in the dog.

Authors:  P Bolme; S H Ngai; S Rosell
Journal:  Acta Physiol Scand       Date:  1967-12

4.  The organization of projections from the cortex, amygdala, and hypothalamus to the nucleus of the solitary tract in rat.

Authors:  D van der Kooy; L Y Koda; J F McGinty; C R Gerfen; F E Bloom
Journal:  J Comp Neurol       Date:  1984-03-20       Impact factor: 3.215

5.  [Neuronal mechanisms of hypothalamic control of sympathetic nervous system activity].

Authors:  O G Baklavadzhian
Journal:  Fiziol Zh       Date:  1978 Sep-Oct

6.  Behavioural and autonomic patterns evoked by stimulation of the lateral hypothalamic area in the cat.

Authors:  B Folkow; E H Rubinstein
Journal:  Acta Physiol Scand       Date:  1965-12

7.  Hemodynamic responses to amygdaloid stimulation in spontaneously hypertensive rats.

Authors:  T M Galeno; M J Brody
Journal:  Am J Physiol       Date:  1983-08

8.  Amygdaloid projections to the mesencephalon, pons and medulla oblongata in the cat.

Authors:  D A Hopkins; G Holstege
Journal:  Exp Brain Res       Date:  1978-08-15       Impact factor: 1.972

9.  [Hypothalamic mechanisms of regulating blood circulation in the coronary and brachial artery systems].

Authors:  O G Baklavadzhian; O K Sarian
Journal:  Fiziol Zh SSSR Im I M Sechenova       Date:  1978-07

10.  [The role of the paraventricular hypothalamic nuclei in the development of chronic neurogenic hypertension and the formation of a self-stimulation reaction].

Authors:  O G Baklavadzhian; A G Darbinian; I Kh Taturian; A V Khachatrian
Journal:  Fiziol Zh Im I M Sechenova       Date:  1994-02
View more
  7 in total

Review 1.  The role of the nervous system in hypertension.

Authors:  J M Wyss; S H Carlson
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  The central amygdala as an integrative hub for anxiety and alcohol use disorders.

Authors:  Nicholas W Gilpin; Melissa A Herman; Marisa Roberto
Journal:  Biol Psychiatry       Date:  2014-09-22       Impact factor: 13.382

Review 3.  Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders.

Authors:  B Myers-Schulz; M Koenigs
Journal:  Mol Psychiatry       Date:  2011-07-26       Impact factor: 15.992

4.  Individual differences in stressor-evoked blood pressure reactivity vary with activation, volume, and functional connectivity of the amygdala.

Authors:  Peter J Gianaros; Lei K Sheu; Karen A Matthews; J Richard Jennings; Stephen B Manuck; Ahmad R Hariri
Journal:  J Neurosci       Date:  2008-01-23       Impact factor: 6.167

5.  Angiotensin II and CRF receptors in the central nucleus of the amygdala mediate hemodynamic response variability to cocaine in conscious rats.

Authors:  Mari A Watanabe; Sarah Kucenas; Tamara A Bowman; Melissa Ruhlman; Mark M Knuepfer
Journal:  Brain Res       Date:  2009-10-30       Impact factor: 3.252

6.  Impaired Kv7 channel activity in the central amygdala contributes to elevated sympathetic outflow in hypertension.

Authors:  Zhao-Fu Sheng; Hua Zhang; PeiRu Zheng; Shanyan Chen; Zezong Gu; Jing-Jing Zhou; Jeffery G Phaup; Hui-Ming Chang; Edward T H Yeh; Hui-Lin Pan; De-Pei Li
Journal:  Cardiovasc Res       Date:  2022-01-29       Impact factor: 13.081

7.  Brain activation in response to visceral stimulation in rats with amygdala implants of corticosterone: an FMRI study.

Authors:  Anthony C Johnson; Brent Myers; Jelena Lazovic; Rheal Towner; Beverley Greenwood-Van Meerveld
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.